Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

AMAM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 0.64%

Insider Buying (Last 12 Months): $28,763,117.06

Insider Selling (Last 12 Months): $616,597.80

Ambrx Biopharma Insider Trading History Chart

Ambrx Biopharma Share Price & Price History

^$28.00

+0.30 (1.20%)

As of 03/7/2024 01:00 AM ET

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Ambrx Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/27/2023	Daniel J O'connor	CEO	Sell	50,012	$9.82	$491,117.84	342,845
10/27/2023	Sonja Nelson	CFO	Sell	12,778	$9.82	$125,479.96	130,079
10/23/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	1,307,311	$6.99	$9,138,103.89	11,231,000
9/18/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	751,233	$9.24	$6,941,392.92	69,465,823
9/15/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	1,401,505	$9.05	$12,683,620.25	68,714,590
4/19/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	135,850	$11.15	$1,514,727.50	9,485,714
4/17/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	562,121	$10.67	$5,997,831.07	62,097,896
4/13/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	1,193,808	$9.16	$10,935,281.28	60,693,808
3/16/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	500,000	$10.15	$5,075,000.00	53,500,000
3/14/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	250,000	$9.95	$2,487,500.00	52,750,000

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for Ambrx Biopharma (NYSE:AMAM)

77.28% of Ambrx Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ambrx Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	1,399,642	$19.93M	0.0%	N/A	2.216%
2/26/2024	Virtu Financial LLC	20,386	$0.29M	0.0%	N/A	0.032%
2/26/2024	Perceptive Advisors LLC	78,811	$1.12M	0.0%	N/A	0.125%
2/22/2024	Sierra Summit Advisors LLC	37,237	$0.53M	0.2%	N/A	0.059%
2/16/2024	Price T Rowe Associates Inc. MD	1,084,247	$15.44M	0.0%	+32.0%	1.717%
2/15/2024	NWI Management LP	53,645	$0.76M	0.0%	-66.7%	0.085%
2/15/2024	Barclays PLC	199,950	$2.85M	0.0%	N/A	0.317%
2/15/2024	Vanguard Group Inc.	1,399,642	$19.93M	0.0%	N/A	2.216%
2/15/2024	Nextech Invest Ltd.	3,129,300	$44.56M	8.3%	N/A	4.955%
2/15/2024	Old Well Partners LLC	14,400	$0.21M	0.2%	N/A	0.023%
2/15/2024	Price T Rowe Associates Inc. MD	1,084,247	$15.44M	0.0%	+32.0%	1.717%
2/15/2024	Parkman Healthcare Partners LLC	87,678	$1.25M	0.2%	-41.5%	0.139%
2/15/2024	Bayesian Capital Management LP	15,804	$0.23M	0.0%	N/A	0.025%
2/14/2024	Royal Bank of Canada	70,094	$1M	0.0%	+978.4%	0.111%
2/14/2024	Altitude Crest Partners Inc.	43,100	$0.61M	0.4%	N/A	0.068%
2/14/2024	Balyasny Asset Management L.P.	2,154,700	$30.68M	0.1%	N/A	3.412%
2/14/2024	Lighthouse Investment Partners LLC	88,925	$1.27M	0.1%	N/A	0.141%
2/13/2024	Tower Research Capital LLC TRC	5,614	$80K	0.0%	+2,288.9%	0.009%
2/13/2024	Goldman Sachs Group Inc.	399,648	$5.69M	0.0%	N/A	0.633%
2/13/2024	The Manufacturers Life Insurance Company	77,472	$1.10M	0.0%	+30.7%	0.123%
2/12/2024	Monashee Investment Management LLC	207,500	$2.96M	0.5%	+196.4%	0.329%
2/12/2024	TD Asset Management Inc	140,256	$2M	0.0%	+27.0%	0.222%
2/6/2024	WuXi AppTec Co. Ltd.	1,000,000	$14.24M	36.9%	N/A	1.584%
1/31/2024	Federated Hermes Inc.	330,949	$4.71M	0.0%	-86.2%	0.524%
1/30/2024	HealthInvest Partners AB	57,847	$0.82M	0.7%	N/A	0.092%
1/24/2024	China Universal Asset Management Co. Ltd.	7,303	$0.10M	0.0%	N/A	0.012%
11/15/2023	Alps Advisors Inc.	45,531	$0.52M	0.0%	+12.2%	0.073%
11/14/2023	Monashee Investment Management LLC	70,000	$0.81M	0.3%	N/A	0.113%
11/13/2023	Federated Hermes Inc.	2,395,867	$27.55M	0.1%	N/A	3.864%
11/13/2023	NWI Management LP	160,935	$1.85M	0.1%	N/A	0.260%
11/13/2023	FMR LLC	1,761,058	$20.25M	0.0%	-20.3%	2.840%
11/9/2023	Innovis Asset Management LLC	31,137	$0.36M	0.1%	+85.1%	0.050%
11/9/2023	UBS Group AG	5,574	$64K	0.0%	-94.2%	0.009%
10/27/2023	TD Asset Management Inc	110,456	$1.27M	0.0%	+73.3%	0.178%
10/24/2023	Bank of New York Mellon Corp	47,433	$0.55M	0.0%	N/A	0.076%
8/15/2023	Point72 Asset Management L.P.	349,938	$5.76M	0.0%	N/A	0.567%
8/15/2023	Silverarc Capital Management LLC	100,000	$1.65M	0.5%	N/A	0.162%
8/15/2023	HighVista Strategies LLC	153,431	$2.53M	1.2%	N/A	0.248%
8/15/2023	Holocene Advisors LP	913,754	$15.04M	0.1%	N/A	1.480%
8/15/2023	Commodore Capital LP	3,175,000	$52.26M	5.9%	-33.9%	5.142%
8/14/2023	Cormorant Asset Management LP	9,616,155	$158.28M	8.9%	+13.1%	15.573%
8/14/2023	Schonfeld Strategic Advisors LLC	98,600	$1.62M	0.0%	+26.1%	0.160%
8/11/2023	VR Adviser LLC	2,484,960	$40.90M	6.5%	-24.7%	4.499%
8/11/2023	The Manufacturers Life Insurance Company	59,197	$0.97M	0.0%	+100.5%	0.107%
8/11/2023	Geode Capital Management LLC	39,438	$0.65M	0.0%	N/A	0.071%
8/11/2023	JPMorgan Chase & Co.	157,858	$2.60M	0.0%	N/A	0.286%
8/11/2023	ExodusPoint Capital Management LP	477,558	$7.86M	0.1%	+2,349.4%	0.865%
8/9/2023	TD Asset Management Inc	63,728	$1.05M	0.0%	+358.5%	0.115%
8/3/2023	Innovis Asset Management LLC	16,826	$0.28M	0.1%	N/A	0.030%
7/20/2023	Exchange Traded Concepts LLC	9,830	$0.16M	0.0%	N/A	0.018%
7/13/2023	QP Wealth Management LLC	12,670	$0.21M	0.3%	N/A	0.023%
5/16/2023	Squarepoint Ops LLC	17,511	$0.16M	0.0%	N/A	0.045%
5/15/2023	Schonfeld Strategic Advisors LLC	78,200	$0.70M	0.0%	N/A	0.202%
5/15/2023	Darwin Global Management Ltd.	11,304,573	$100.84M	27.6%	+49.0%	29.259%
5/15/2023	Nomura Holdings Inc.	57,268	$0.51M	0.0%	N/A	0.148%
5/15/2023	Commodore Capital LP	4,803,447	$42.85M	6.5%	N/A	12.433%
5/15/2023	Price T Rowe Associates Inc. MD	210,627	$1.88M	0.0%	N/A	0.545%
5/15/2023	Ghost Tree Capital LLC	250,000	$2.23M	0.7%	N/A	0.647%
5/15/2023	Farallon Capital Management LLC	361,000	$3.22M	0.0%	N/A	0.934%
5/11/2023	FMR LLC	2,210,618	$19.72M	0.0%	-18.0%	5.721%
5/11/2023	ExodusPoint Capital Management LP	19,497	$0.17M	0.0%	N/A	0.050%
5/10/2023	Tocqueville Asset Management L.P.	12,500	$0.11M	0.0%	N/A	0.032%
5/9/2023	Tower Research Capital LLC TRC	20,440	$0.18M	0.0%	+681,233.3%	0.053%
4/28/2023	Fosun International Ltd	249,190	$2.22M	0.2%	-87.1%	0.645%
3/15/2023	B. Riley Wealth Advisors Inc.	20,000	$45K	0.0%	N/A	0.052%
2/21/2023	B. Riley Wealth Advisors Inc.	20,000	$45K	0.0%	N/A	0.052%
2/15/2023	Millennium Management LLC	18,793	$43K	0.0%	-83.5%	0.049%
2/14/2023	Alpine Global Management LLC	46,723	$0.11M	0.0%	N/A	0.121%
2/13/2023	Renaissance Technologies LLC	32,500	$74K	0.0%	-49.2%	0.084%
11/14/2022	Royal Bank of Canada	42,453	$46K	0.0%	N/A	0.110%
11/14/2022	Cormorant Asset Management LP	2,336,389	$2.52M	0.2%	-6.0%	6.050%
11/14/2022	Renaissance Technologies LLC	64,000	$69K	0.0%	+481.8%	0.166%
8/13/2022	Renaissance Technologies LLC	11,000	$29K	0.0%	-51.3%	0.029%
8/12/2022	FMR LLC	3,857,679	$10.22M	0.0%	+0.8%	9.997%
5/16/2022	Suvretta Capital Management LLC	1,491,832	$6.15M	0.2%	+41.0%	3.866%
5/13/2022	Renaissance Technologies LLC	22,600	$93K	0.0%	+91.5%	0.059%
5/12/2022	BlackRock Inc.	2,851,486	$11.75M	0.0%	-0.6%	7.389%
2/15/2022	Adage Capital Partners GP L.L.C.	1,923,700	$17.37M	0.0%	+5.3%	5.107%
2/14/2022	Suvretta Capital Management LLC	1,057,735	$9.55M	0.2%	N/A	2.808%
11/15/2021	Tudor Investment Corp Et Al	20,143	$0.27M	0.0%	-66.4%	0.053%
11/12/2021	Ghisallo Capital Management LLC	15,000	$0.20M	0.0%	-62.5%	0.040%
11/9/2021	BlackRock Inc.	820,221	$11.07M	0.0%	-3.6%	2.177%
8/25/2021	Marshall Wace North America L.P.	32,648	$0.64M	0.0%	N/A	0.087%
8/17/2021	Millennium Management LLC	144,092	$2.82M	0.0%	N/A	0.383%
8/17/2021	Octagon Capital Advisors LP	450,000	$8.82M	1.8%	N/A	1.195%
8/17/2021	Boothbay Fund Management LLC	13,422	$0.26M	0.0%	N/A	0.036%
8/17/2021	Caas Capital Management LP	40,000	$0.78M	0.0%	N/A	0.106%
8/16/2021	Tudor Investment Corp Et Al	60,000	$1.18M	0.0%	N/A	0.159%
8/13/2021	FMR LLC	3,766,940	$68.73M	0.0%	N/A	10.000%
8/12/2021	Fosun International Ltd	1,932,591	$37.88M	2.2%	N/A	5.130%
8/12/2021	Monashee Investment Management LLC	110,000	$2.16M	0.3%	N/A	0.292%
8/11/2021	BlackRock Inc.	850,676	$16.67M	0.0%	N/A	2.258%
7/30/2021	Alliancebernstein L.P.	70,000	$1.37M	0.0%	N/A	0.186%

Data available starting January 2016

Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California.

Today's Range

Now: $28.00

$28.00

50 Day Range

MA: $27.94

$27.70

$28.00

52 Week Range

Now: $28.00

$6.55

$28.15

Volume

N/A

Average Volume

2,123,967 shs

Market Capitalization

$1.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Ambrx Biopharma?: Ambrx Biopharma's top insider investors include:
Cormorant Asset Management, Lp (Major Shareholder)
Daniel J O'connor (CEO)
Sonja Nelson (CFO)
Learn More about top insider investors at Ambrx Biopharma.